News and views on thioredoxin reductases

Redox Report

Volumn 4, Issue 5, 1999, Pages 221-228

  Gromer, Stephan ^a   Schirmer, R Heiner ^a   Becker, Katja ^b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Zentrum für Infektionsforschung   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; SELENIUM DERIVATIVE; THIOREDOXIN REDUCTASE;

BIOSENSOR; CANCER; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME PURIFICATION; HUMAN; MALARIA; MAMMAL; NOMENCLATURE; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS; VIRUS INFECTION;

MAMMALIA;

EID: 0033388744     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100099101534936     Document Type: Review

References (110)

1. Holmgren A. Thioredoxin and glutaredoxin systems. J Biol Chem 1989; 264: 13963-13966.
2. Holmgren A. Regulation of ribonucleotide reductase. Curr Top Cell Regul 1981; 19: 47-76.
3. Spyrou G, Holmgren A. Deoxyribonucleoside triphosphate pools and growth of glutathione-depleted 3T6 mouse fibroblasts. Biochem Biophys Res Commun 1996; 220: 42-46.
4. Williams CHJ. Lipoamide dehydrogenase, glutathione reductase, thioredoxin reductase, and mercuric ion reductase - a family of flavoenzyme transhydrogenases. In: Müller F ed. Chemistry and Biochemistry of Flavoenzymes, Vol. 3. Boca Raton: CRC Press, 1992: 121-211.
5. Kuriyan J, Wong L, Russel M, Model P. Crystallization and preliminary x-ray characterization of thioredoxin reductase from Escherichia coll. J Biol Chem 1989; 264: 12752-12753.
6. Kuriyan J, Krishna TS, Wong L et al. Convergent evolution of similar function in two structurally divergent enzymes. Nature 1991; 352: 172-174.
7. Williams Jr CH, Mechanism and structure of thioredoxin reductase from Escherichia coli. FASEB J 1995; 9: 1267-1276.
8. Lennon BW, Williams CJ. Enzyme-monitored turnover of Escherichia coli thioredoxin reductase: insights for catalysis. Biochemistry 1996; 35: 4704-4712.
9. Arscott LD, Gromer S, Schirmer RH, Becker K, Williams Jr CH. The mechanism of thioredoxin reductase from human placenta is similar to the mechanisms of lipoamide dehydrogenase and glutathione reductase and is distinct from the mechanism of thioredoxin reductase from Escherichia coli. Proc Natl Acad Sci USA 1997; 94: 3621-3626.
10. Amer ES, Nordberg J, Holmgren A. Efficient reduction of lipoamide and lipoic acid by mammalian thioredoxin reductase. Biochem Biophys Res Commun 1996; 225: 268-274.
11. Bjornstedt M, Hamberg M, Kumar S, Xue J, Holmgren A. Human thioredoxin reductase directly reduces lipid hydroperoxides by NADPH and selenocystine strongly stimulates the reaction via catalytically generated selenols. J Biol Chem 1995; 270: 11761-11764.
12. Nikitovic D, Holmgren A. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J Biol Chem 1996; 271: 19180-19185.
13. Luthman M, Holmgren A. Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry 1982; 21: 6628-6633.
14. May JM, Mendiratta S, Hill KE, Burk RF. Reduction of dehydroascorbate to ascorbate by the selenoenzyme thioredoxin reductase. J Biol Chem 1997; 272: 22607-22610.
15. Holmgren A, Lyckeborg C. Enzymatic reduction of alloxan by thioredoxin and NADPH-thioredoxin reductase. Proc Natl Acad Sci USA 1980; 77: 5149-5152.
16. Holmgren A. Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction. J Biol Chem 1977; 252: 4600-4606.
17. Oblong JE, Gasdaska PY, Sherrill K, Powis G. Purification of human thioredoxin reductase: properties and characterization by absorption and circular dichroism spectroscopy. Biochemistry 1993; 32: 7271-7277.
18. Lundstrom-Ljung J, Birnbach U, Rupp K, Soling HD, Holmgren A. Two resident ER-proteins, CaBP1 and CaBP2, with thioredoxin domains, are substrates for thioredoxin reductase: comparison with protein disulfide isomerase. FEBS Lett 1995; 357: 305-308.
19. Andersson M, Holmgren A, Spyron G. NK-lysin, a disulfide-containing effector peptide of T-lymphocytes, is reduced and inactivated by human thioredoxin reductase. Implication for a protective mechanism against NK-lysin cytotoxicity. J Biol Chem 1996; 271: 10116-10120.
20. Lundstrom J, Holmgren A. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity. J Biol Chem 1990; 265: 9114-9120.
21. Bjornstedt M, Xue J, Huang W, Akesson B, Holmgren A. The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. J Biol Chem 1994; 269: 29382-29384.
22. Weichsel A, Gasdaska JR, Powis G, Montfort WR. Crystal structures of reduced, oxidized, and mutated human thioredoxins: evidence for a regulatory homodimer. Structure 1996; 4: 735-751.
23. Follmann H, Haberlein I. Thioredoxins: universal, yet specific thiol-disulfide redox cofactors. Biofactors 1995; 5: 147-156.
24. Martin JE. Thioredoxin - a fold for all reasons. Structure 1995; 3: 245-250.
25. Nakshatri H, Bhat-Nakshatri P, Currie RA. Subunit association and DNA binding activity of the heterotrimeric transcription factor NF-Y is regulated by cellular redox. J Biol Che, 1996; 271: 28784-28791.
26. Kambe F, Nomura Y, Okamoto T, Seo H. Redox regulation of thyroid-transcription factors, Pax-8 and TTF-1, is involved in their increased DNA-binding activities by thyrotropin in rat thyroid FRTL-5 cells. Mol Endocrinol 1996; 10: 801-812.
27. Flohe E, Brigelius-Flohe R, Saliou C, Traber MG, Packer L. Redox regulation of NF-kappa B activation. Free Radic Biol Med 1997; 22: 1115-1126.
28. Grippo JF, Tienrungroj W, Dahmer MK, Housley PR, Pratt WB. Evidence that the endogenous heat-stable glucocorticoid receptor-activating factor is thioredoxin. J Biol Chem 1983; 258: 13658-13664.
29. Grippo JF, Holmgren A, Pratt WB. Proof that the endogenous, heat-stable glucocorticoid receptor-activating factor is thioredoxin. J Biol Chem 1985; 260: 93-97.
30. Hunt T, Herbert P, Campbell EA, Delidakis C, Jackson RJ. The use of affinity chromatography on 2′5′-ADP-Sepharose reveals a requirement for NADPH. thioredoxin and thioredoxin reductase for the maintenance of high protein synthesis activity in rabbit reticulocyte lysates. Eur J Biochem 1983; 131: 303-311.
31. Jackson RJ, Campbell EA, Herbert P, Hunt T. The preparation and properties of gel-filtered rabbit-reticulocyte lysate protein-synthesis systems. Eur J Biochem 1983; 131: 289-301.
32. Soute BA, Groenen-van Dooren MM, Holmgren A, Lundstrom J, Vermeer C. Stimulation of the dithiol-dependent reductases in the vitamin K cycle by the thioredoxin system. Strong synergistic effects with protein disulphide-isomerase. Biochem J 1992; 281: 255-259.
33. Holmgren A. Reduction of disulfides by thioredoxin. Exceptional reactivity of insulin and suggested functions of thioredoxin in mechanism of hormone action. J Biol Chem 1979; 254: 9113-9119.
34. Patel JM, Zhang J, Block ER. Nitric oxide-induced inhibition of lung endothelial cell nitric oxide synthase via interaction with allosteric thiols: role of thioredoxin in regulation of catalytic activity. Am J Respir Cell Mol Biol 1996; 15: 410-419.
35. Fernando MR, Nanri H, Yoshitake S, Nagata-Kuno K, Minakami S. Thioredoxin regenerates proteins inactivated by oxidative stress in endothelial cells. Eur J Biochem 1992; 209: 917-922.
36. Powis G, Oblong JE, Gasdaska PY, Berggren M, Hill SR, Kirkpatrick DL. The thioredoxin/thioredoxin reductase redox system and control of cell growth. Oncol Res 1994; 6: 539-544.
37. Gasdaska JR, Berggren M, Powis G. Cell growth stimulation by the redox protein thioredoxin occurs by a novel helper mechanism. Cell Growth Differ 1995; 6: 1643-1650.
38. Tamura T, Stadtman TC. A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. Proc Natl Acad Sci USA 1996; 93: 1006-1011.
39. Gladyshev VN, Jeang KT, Stadtman TC. Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc Natl Acad Sci USA 1996; 93: 6146-6151.
40. Gasdaska PY, Gasdaska JR, Cochran S, Powis G. Cloning and sequencing of a human thioredoxin reductase. FEBS Lett 1995; 373: 5-9.
41. Müller S, Gilberger TW, Farber PM, Becker K, Schirmer RH, Walter RD. Recombinant putative glutathione reductase of Plasmodium falciparum exhibits thioredoxin reductase activity. Mol Biochem Parasitol 1996; 80: 215-219.
42. Zhong L, Arnér ES, Ljung J, Åslund F, Holmgren A. Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue. J Biol Chem 1998; 273: 8581-8591.
43. Gromer S, Schirmer RH, Becker K. The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase. FEBS Lett 1997; 412: 318-320.
44. Stadtman TC. Selenocysteine. Annu Rev Biochem 1996; 65: 83-100.
45. Low SC, Berry MJ. Knowing when not to stop: selenocysteine incorporation in eukaryotes. Trends Biochem 1996; 21: 203-208.
46. Arnér ESJ, Sarioglu H, Lottspeich F, Holmgren A, Böck A. High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes. J Mol Biol 1999; 292: 1003-1016.
47. Fujiwara N, Fujii T, Fujii J, Taniguchi N. Functional expression of rat thioredoxin reductase: selenocysteine insertion sequence element is essential for the active enzyme. Biochem J 1999; 340: 439-444.
48. Marcocci L, Flohe L, Packer L. Evidence for a functional relevance of the selenocysteine residue in mammalian thioredoxin reductase. Biofactors 1997; 6: 351-358.
49. Hill KE, McCollum GW, Boeglin ME, Burk RF. Thioredoxin reductase activity is decreased by selenium deficiency. Biochem Biophys Res Commun 1997; 234: 293-295.
50. Gromer S, Wissing J, Behne D et al. A hypothesis on the catalytic mechanism of the selenoenzyme thioredoxin reductase. Biochem J 1998; 332: 591-592.
51. Gorlatov SN, Stadtman TC. Human thioredoxin reductase from HeLa cells: selective alkylation of selenocysteine in the protein inhibits enzyme activity and reduction with NADPH influences affinity to heparin. Proc Natl Acad Sci USA 1998; 95: 8520-8525.
52. Holmgren A. Biochemistry of sulfur, selenium and the halogens. GBCh-GBM Congres presentation (Kassel, Germany) 1997; 13.3.
53. Gromer S, Arscott LD, Williams Jr CH, Schirmer RH, Becker K. Human placenta thioredoxin reductase. Isolation of the selenoenzyme, steady state kinetics, and inhibition by therapeutic gold compounds. J Biol Chem 1998; 273: 20096-20101.
54. Holmgren A, Luthman M. Tissue distribution and subcellular localization of bovine thioredoxin determined by radioimmunoassay. Biochemistry 1978; 17: 4071-4077.
55. Rozell B, Hansson HA, Luthman M, Holmgren A. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. Eur J Cell Biol 1985; 38: 79-86.
56. Rozell B, Holmgren A, Hansson HA. Ultrastructural demonstration of thioredoxin and thioredoxin reductase in rat hepatocytes. Eur J Cell Biol 1988; 46: 470-477.
57. Schallreuter KU, Wood JM. The activity and purification of membrane-associated thioredoxin reductase from human metastatic melanotic melanoma. Biochim Biophys Acta 1988; 967: 103-109.
58. Wollman EE, Kahan A, Fradelizi D. Detection of membrane associated thioredoxin on human cell lines. Biochem Biophys Res Commun 1997; 230: 602-606.
59. Rubartelli A, Bajetto A, Allavena G, Wollman E, Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem 1992; 267: 24161-24164.
60. Gasdaska PY, Oblong JE, Cotgreave IA, Powis G. The predicted amino acid sequence of human thioredoxin is identical to that of the autocrine growth factor human adult T-cell derived factor (ADF): thioredoxin mRNA is elevated in some human tumors. Biochim Biophys Acta 1994; 1218: 292-296.
61. Wakasugi N, Tagaya Y, Wakasugi H et al. Adult T-cell leukemia-derived factor/thioredoxin, produced by both human T-lymphotropic virus type I- and Epstein-Barr virus-transformed lymphocytes, acts as an autocrine growth factor and synergizes with interleukin 1 and interleukin 2. Proc Natl Acad Sci USA 1990; 87: 8282-8286.
62. Tagaya Y, Maeda Y, Mitsui A et al. ATL-derived factor (ADF), an IL-2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol-reduction in the IL-2 receptor induction. EMBO J 1989; 8: 757-764.
63. Tagaya Y, Wakasugi H, Masutani H et al. Role of ATL-derived factor (ADF) in the normal and abnormal cellular activation: involvement of dithiol related reduction. Mol Immunol 1990; 27: 1279-1289.
64. Powis G, Kirkpatrick DL, Angulo M, Baker A. Thioredoxin redox control of cell growth and death and the effects of inhibitors. Chem Biol Interact 1998; 111/112: 23-34.
65. Powis G, Briehl M, Oblong J. Redox signalling and the control of cell growth and death. Pharmacol Ther 1995; 68: 149-173.
66. Schirmer RH, Schulz GE, Untucht-Grau R. On the geometry of leukocyte NADPH-oxidase, a membrane flavoenzyme. Inferences from the structure of glutathione reductase. FEBS Lett 1983; 154; 1-4.
67. Preusch PC. Is thioredoxin the physiological vitamin K epoxide reducing agent? FEBS Lett 1992; 305: 257-259.
68. Bodenstein J, Follmann H. Characterization of two thioredoxins in pig heart including a new mitochondrial protein. Z Naturforsch 1991; 46: 270-279.
69. Spyrou G, Enmark E, Miranda-Vizuete A, Gustafsson J. Cloning and expression of a novel mammalian thioredoxin. J Biol Chem 1997; 272: 2936-2941.
70. Lee SR, Kim JR, Kwon KS et al. Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver. J Biol Chem 1999; 274: 4722-4734.
71. Rigobello MP, Callegaro MT, Barzon E, Benetti M, Bindoli A. Purification of mitochondrial thioredoxin reductase and its involvement in the redox regulation of membrane permeability. Free Radic Biol Med 1998; 24: 370-376.
72. Gasdaska PY, Berggren MM, Berry MJ, Powis G. Cloning, sequencing and functional expression of a novel human thioredoxin reductase. FEBS Lett 1999; 442: 105-111.
73. Miranda-Vizuete A, Damdimopoulos AE, Pedrajas JR, Gustafsson JA, Spyrou G. Human mitochondrial thioredoxin reductase cDNA cloning, expression and genomic organization. Eur J Biochem 1999; 261: 405-412.
74. Gladyshev VN, Kratise M, Xu XM et al. Selenocysteine-containing thioredoxin reductase in C. elegans. Biochem Biophys Res Commun 1999; 259: 244-249.
75. Sun Q-A, Wu Y, Zappacosta F et al. Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. J Biol Chem 1999; 274: 24522-24530.
76. Gasdaska JR, Gasdaska PY, Gallegos A, Powis G. Human thioredoxin reductase gene localization to chromosomal position 12q23-q24.1 and mRNA distribution in human tissue. Genomics 1996; 37: 257-259.
77. Silaeva SA, Danilova NI, Debov SS. Various properties of ribonucleotide reductase from rat liver mitochondria. Biokhimiia 1975; 40: 711-715.
78. Young P, Leeds JM, Slabaugh MB, Mathews CK. Ribonucleotide reductase: evidence for specific association with HeLa cell mitochondria. Biochem Biophys Res Commun 1994; 203: 46-52.
79. Watabe S, Hiroi T, Yamamoto Y et al. SP-22 is a thioredoxin-dependent peroxide reductase in mitochondria. Eur J Biochem 1997; 249: 52-60.
80. Gauntt CD, Ohira A, Honda O et al. Mitochondrial induction of adult T cell leukemia derived factor (ADF/hTx) after oxidative stresses in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 1994; 35: 2916-2923.
81. Das KC, Lewis-Molock Y, White CW. Elevation of manganese superoxide dismutase gene expression by thioredoxin. Am J Respir Cell Mol Biol 1997; 17: 713-726.
82. Wudarczyk J, Debska G, Lenartowicz E. Relation between the activities reducing disulfides and the protection against membrane permeability transition in rat liver mitochondria. Arch Biochem Biophvs 1996; 327: 215-221.
83. Mau BL, Powis G. Inhibition of thioredoxin reductase (E.C. 1.6.4.5) by antitumor quinones. Free Radic Res Commun 1990; 8: 365-372.
84. Mau BL, Powis G. Inhibition of cellular thioredoxin reductase by diaziquone and doxorubicin. Relationship to the inhibition of cell proliferation and decreased ribonucleotide reductase activity. Biochem Pharmacol 1992; 43: 1621-1627.
85. Mau BL, Powis G. Mechanism-based inhibition of thioredoxin reductase by antitumor quinoid compounds. Biochem Pharmacol 1992; 43: 1613-1620.
86. Coudray C, Boucher F, Hida H, Tirard V, Leiris JD, Favier A. Selenium supplementation decreases the pro-oxidant and cardiotoxicity effects of adriamycin in the rat. Redox Report 1996; 2: 323-332.
87. Nordberg J, Zhong L, Holmgren A, Arner ES. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J Biol Chem 1998; 273: 10835-10842.
88. Arner ES, Bjornstedt M, Holmgren A. 1-Chloro-2,4-dinitrobenzene is an irreversible inhibitor of human thioredoxin reductase. Loss of thioredoxin disulfide reductase activity is accompanied by a large increase in NADPH oxidase activity. J Biol Chem 1995; 270: 3479-3482.
89. Gladyshev VN, Factor VM, Housseau F, Hatfield DL. Contrasting patterns of regulation of the antioxidant selenoproteins, thioredoxin reductase, and glutathione peroxidase, in cancer cells. Biochem Biophys Res Commun 1998; 251: 488-493.
90. Chen CC, McCall BL, Moore EC. Purification of thioredoxin reductase from the Novikoff rat tumor. Prep Biochem 1977; 7: 165-177.
91. Biguet C, Wakasugi N, Mishal Z et al. Thioredoxin increases the proliferation of human B-cell lines through a protein kinase C-dependent mechanism. J Biol Chem 1994; 269: 28865-28870.
92. Rainwater R, Parks D, Anderson ME, Tegtmeyer P, Mann K. Role of cysteine residues in regulation of p53 function. Mol Cell Biol 1995; 15: 3892-3902.
93. Sun Y, Oberley LW. Redox regulation of transcriptional activators. Free Radic Biol Med 1996; 21: 335-348.
94. Muro Y, Ogawa Y, Kato Y, Hagiwara M. Autoantibody to thioredoxin reductase in an ovarian cancer patient. Biochem Biophys Res Commun 1998; 242: 267-271.
95. Schallreuter KU, Gleason FK, Wood JM. The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase. Biochim Biophys Acta 1990; 1054: 14-20.
96. Schallreuter KU, Wood JM. Sensitivity and resistance in human metastatic melanoma to the new chloroethylnitrosourea antitumor drug fotemustine. Biochim Biophys Acta 1991; 1096: 277-283.
97. Stahl W, Krauth-Siegel RL, Schirmer RH, Eisenbrand G. A method to determine the carbamoylating potential of 1-(2-chloroethyl)-1-nitrosoureas. IARC Sci Publ 1987; 84: 191-193.
98. Hofmann ER, Boyanapalli M, Lindner DJ et al. Thioredoxin reductuse mediates cell death effects of the combination of beta interferon and retinoic acid. Mol Cell Biol 1998; 18: 6493-6504.
99. Nordhoff A, Tziatzios C, van den Broek JA et al. Denaturation and reactivation of dimeric human glutathione reductase - an assay for folding inhibitors. Eur J Biochem 1997; 245: 273-282.
100. Davioud-Charvet E, Becker k, Landry V, Gromer S, Loge C, Sergheraert C. Synthesis of 5,5′-dithiobis(2-nitrobenzamides) as alternative substrates for trypanothione reductase and thioredoxin reductase: a microtiter colorimetric assay for inhibitor screening. Anal Biochem 1999; 268: 1-8.
101. Saito I, Shimuta M, Terauchi K, Tsubota K, Yodoi J, Miyasaka N. Increased expression of human thioredoxin/adult T cell leukemia-derived factor in Sjögren's syndrome. Arthritis Rheum 1996; 39: 773-782.
102. Smith AD, Guidry CA, Morris VC, Levander OA. Aurothioglucose inhibits murine thioredoxin reductase activity in vivo. J Nutr 1999; 129: 194-198.
103. Nakamura H, De Rosa S, Roederer M et al. Elevation of plasma thioredoxin levels in HIV-infected individuals. Int Immunol 1996; 8: 603-611.
104. Newman GW, Balcewicz-Sablinska MK, Guarnaccia JR, Remold HG, Silberstein DS. Opposing regulatory effects of thioredoxin and eosinophil cytotoxicity-enhancing factor on the development of human immunodeficiency virus 1. J Exp Med 1994; 180: 359-363.
105. Becker K, Gui M, Traxler A, Kirsten C, Schirmer RH. Redox processes in malaria and other parasitic diseases. Determination of intracellular glutathione. Histochemistry 1994; 102: 389-395.
106. Gilberger TW, Bergmann B, Walter RD, Muller S. The role of the C-terminus for catalysis of the large thioredoxin reductase from Plasmodium falciparum. FEBS Lett 1998; 425: 407-410.
107. Wang PF, Marcinkeviciene J, Williams Jr CH, Blanchard JS. Thioredoxin reductase-thioredoxin fusion enzyme from Mycobacterium leprae: comparison with the separately expressed thioredoxin reductase. Biochemistry 1998; 37: 16378-16389.
108. Rafferty TS, McKenzie RC, Hunter JA et al. Differential expression of selenoproteins by human skin cells and protection by selenium from UVB-radiation-induced cell death. Biochem J 1998; 332: 231-236.
109. Korac B, Buzadzic B, Saicic ZS, Radojicic R, Petrovic VM. Effect of selenium-enriched yeast pretreatment on the antioxidative defense in the skin of rats exposed to heat shock. J Environ Pathol Toxicol Oncol 1998; 17: 305-311.
110. Brown DM, Upcroft JA, Upcroft P. A thioredoxin reductase-class of disulphide reductase in the protozoan parasite Giardia duodenalis. Mol Biochem Parasitol 1996; 83: 211-220.